Long-term treatment with nicotine suppresses neurotoxicity of, and microglial activation by, thrombin in cortico-striatal slice cultures

European Journal of Pharmacology

Volumn 602, Issue 2-3, 2009, Pages 288-293

  Ohnishi, Masatoshi ^a   Katsuki, Hiroshi ^b   Takagi, Mikako ^a   Kume, Toshiaki ^a   Akaike, Akinori ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Hemorrhagic stroke; Microglia; Nicotine; Thrombin

Indexed keywords

DIHYDRO BETA ERYTHROIDINE; MECAMYLAMINE; METHYLLYCACONITINE; NICOTINE; THROMBIN;

ACUTE DRUG ADMINISTRATION; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CHRONIC DRUG ADMINISTRATION; CORPUS STRIATUM; DRUG ANTAGONISM; DRUG MECHANISM; MICROGLIA; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; MICROGLIA; NEOSTRIATUM; NEUROPROTECTIVE AGENTS; NEUROTOXINS; NICOTINE; PARIETAL LOBE; RATS; RATS, WISTAR; RECEPTORS, NICOTINIC; THROMBIN; TIME FACTORS;

EID: 58149144570     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.11.041     Document Type: Article

References (30)

1. Brett K., Parker R., Wittenauer S., Hayashida K., Young T., and Vincler M. Impact of chronic nicotine on sciatic nerve injury in the rat. J. Neuroimmunol. 186 (2007) 37-44
2. Choi S.-H., Lee D.Y., Chung E.S., Hong Y.B., Kim S.U., and Jin B.K. Inhibition on thrombin-induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo. J. Neurochem. 95 (2005) 1755-1765
3. Donovan F.M., Pike C.J., Cotman C.W., and Cunningham D.D. Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J. Neurosci. 17 (1997) 5316-5326
4. Fayad P.B., and Awad I.A. Surgery for intracerebral hemorrhage. Neurology 51 (1998) S69-73
5. Fenster C.P., Beckman M.L., Parker J.C., Sheffield E.B., Whitworth T.L., Quick M.W., and Lester R.A. Regulation of α4β2 nicotinic receptor desensitization by calcium and protein kinase C. Mol. Pharmacol. 55 (1999) 432-443
6. Fujimoto S., Katsuki H., Kume T., and Akaike A. Thrombin-induced delayed injury involves multiple and distinct signaling pathways in the cerebral cortex and the striatum in organotypic slice cultures. Neurobiol. Dis. 22 (2006) 130-142
7. Fujimoto S., Katsuki H., Ohnishi M., Takagi M., Kume T., and Akaike A. Thrombin induces striatal neurotoxicity depending on mitogen-activated protein kinase pathways in vivo. Neuroscience 144 (2007) 694-701
8. Fujimoto S., Katsuki H., Ohnishi M., Takagi M., Kume T., and Akaike A. Plasminogen potentiates thrombin cytotoxicity and contributes to pathology of intracerebral hemorrhage in rats. J. Cereb. Blood Flow Metab. 28 (2008) 506-515
9. Hogg R.C., Raggenbass M., and Bertrand D. Nicotinic acetylcholine receptors: from structure to brain function. Rev. Physiol. Biochem. Pharmacol. 147 (2003) 1-46
10. Kaneko S., Maeda T., Kume T., Kochiyama H., Akaike A., Shimohama S., and Kimura J. Nicotine protects cultured cortical neurons against glutamate-induced cytotoxicity via α7-neuronal receptors and neuronal CNS receptors. Brain Res. 765 (1997) 135-140
11. Katsuki H., Okawara M., Shibata H., Kume T., and Akaike A. Nitric oxide-producing microglia mediate thrombin-induced degeneration of dopaminergic neurons in rat midbrain slice culture. J. Neurochem. 97 (2006) 1232-1242
12. Kihara T., Shimohama S., Sawada H., Honda K., Nakamizo T., Shibasaki H., Kume T., and Akaike A. α7 Nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block a β-amyloid-induced neurotoxicity. J. Biol. Chem. 276 (2001) 13541-13546
13. Kishi M., and Steinbach J.H. Role of the agonist binding site in up-regulation of neuronal nicotinic α4β2 receptors. Mol. Pharmacol. 70 (2006) 2037-2044
14. Kitaoka T., Hua Y., Xi G., Hoff J.T., and Keep R.F. Delayed argatroban treatment reduces edema in a rat model of intracerebral hemorrhage. Stroke 33 (2002) 3012-3018
15. Mogg A.J., Whiteaker P., McIntosh J.M., Marks M., Collins A.C., and Wonnacott S. Methyllycaconitine is a potent antagonist of α-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum. J. Pharmacol. Exp. Ther. 302 (2002) 197-204
16. Mudo G., Belluardo N., and Fuxe K. Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms. J. Neural Transm. 114 (2007) 135-147
17. Nguyen H.N., Rasmussen B.A., and Perry D.C. Binding and functional activity of nicotinic cholinergic receptors in selected rat brain regions are increased following long-term nicotine treatment. J. Neurochem. 90 (2004) 40-49
18. Ohnishi M., Katsuki H., Fujimoto S., Takagi M., Kume T., and Akaike A. Involvement of thrombin and mitogen-activated protein kinase pathways in hemorrhagic brain injury. Exp. Neurol. 206 (2007) 43-52
19. Park H.J., Lee P.H., Ahn Y.W., Choi Y.J., Lee G., Lee D.-Y., Chung E.S., and Jin B.K. Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action. Eur. J. Neurosci. 26 (2007) 79-89
20. Ryu J., Pyo H., Jou I., and Joe E. Thrombin induces NO release from cultured rat microglia via protein kinase C, mitogen-activated protein kinase, and NF-κB. J. Biol. Chem. 275 (2000) 29955-29959
21. Shytle R.D., Mori T., Townsend K., Vendrame M., Sun N., Zeng J., Ehrhart J., Silver A.A., Sanberg P.R., and Tan J. Cholinergic modulation of microglial activation by α7 nicotinic receptors. J. Neurochem. 89 (2004) 337-343
22. Steiner R.C., Heath C.J., and Picciotto M.R. Nicotine-induced phosphorylation of ERK in mouse primary cortical neurons: evidence for involvement of glutamatergic signaling and CaMKII. J. Neurochem. 103 (2007) 666-678
23. Suo Z., Wu M., Ameenuddin S., Anderson H.E., Zoloty J.E., Citron B.A., Andrade-Gordon P., and Festoff B.W. Participation of protease-activated receptor-1 in thrombin-induced microglial activation. J. Neurochem. 80 (2002) 655-666
24. Suo Z., Wu M., Citron B.A., Palazzo R.E., and Festoff B.W. Rapid tau aggregation and delayed hippocampal neuronal death induced by persistent thrombin signaling. J. Biol. Chem. 278 (2003) 37681-37689
25. 3 pathway and modulate the cell activation toward a neuroprotective role. J. Neurosci. Res. 83 (2006) 1461-1470
26. Takada-Takatori Y., Kume T., Sugimoto M., Katsuki H., Sugimoto H., and Akaike A. Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade. Neuropharmacology 51 (2006) 474-486
27. Vallejo Y.F., Buisson B., Bertrand D., and Green W.N. Chronic nicotine exposure upregulates nicotinic receptors by a novel mechanism. J. Neurosci. 25 (2005) 5563-5572
28. Wonnacott S., Barik J., Dickinson J., and Jones I.W. Nicotinic receptors modulate transmitter cross talk in the CNS: nicotinic modulation of transmitters. J. Mol. Neurosci. 30 (2006) 137-140
29. Xi G., Keep R.F., and Hoff J.T. Mechanisms of brain injury after intracerebral hemorrhage. Lancet Neurol. 5 (2006) 53-63
30. Yamazaki Y., Jia Y., Wong J.K., and Sumikawa K. Chronic nicotine-induced switch in Src-family kinase signaling for long-term potentiation induction in hippocampal CA1 pyramidal cells. Eur. J. Neurosci. 24 (2006) 3271-3284